Mediwound Ltd (MDWD)

Currency in USD
14.120
+0.020(+0.14%)
Closed·
14.1200.000(0.00%)
·
Advertisement
Earnings results expected in 12 days
MDWD is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
13.91014.565
52 wk Range
13.54020.300
Key Statistics
Prev. Close
14.1
Open
14.1
Day's Range
13.91-14.565
52 wk Range
13.54-20.3
Volume
75.36K
Average Volume (3m)
90.26K
1-Year Change
-23.7992%
Book Value / Share
3.22
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MDWD Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
30.167
Upside
+113.64%
Members' Sentiments
Bearish
Bullish
ProTips
2 analysts have revised their earnings downwards for the upcoming period

Mediwound Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Analyst Ratings

6 Buy
0 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 30.167
(+113.64% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Oppenheimer
Buy32.00+126.63%33.00Maintain27/05/2026
H.C. Wainwright
Buy36.00+154.96%31.00Maintain21/11/2025

Mediwound Ltd Earnings Call Summary for Q4/2024

  • Q4 2024 EPS of -$0.36 beat expectations; revenue reached $5.84M, slightly above forecast
  • Full-year 2024 revenue increased to $20.2M from $18.7M in 2023; net loss of $30.2M or $3.03 per share
  • NexoBrid 2025 revenue projected at $24M; Phase 3 VLU Global Trial for EscharEx interim analysis expected mid-2026
  • Stock closed at $19.19, down 0.42% pre-market despite earnings beat; analysts maintain bullish outlook
  • Strong liquidity with current ratio of 2.11; cash position of $43.6M at year-end
Last Updated: 19/03/2025, 13:40
Read Full Transcript

Earnings

Latest Release
27/05/2026
EPS / Forecast
-0.23 / -0.65
Revenue / Forecast
1.48M / 3.28M
EPS Revisions
Last 90 days

Compare MDWD to Peers and Sector

Metrics to compare
MDWD
Peers
Sector
Relationship
P/E Ratio
−7.0x−1.4x−0.3x
PEG Ratio
0.99−0.150.00
Price/Book
4.4x0.9x2.6x
Price / LTM Sales
12.5x1.1x3.0x
Upside (Analyst Target)
119.5%45.2%56.7%
Fair Value Upside
Unlock18.1%9.4%Unlock

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic therapy for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.

Employees
121

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
1.91M14.89%27.03M
Other Institutional Investors
9.15M71.21%129.23M
Public Companies & Retail Investors
1.79M13.90%25.22M
Total
12.85M100.00%181.47M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Clal Life Sciences L.P.9.12%1,172,71016,559
HOLD Fund Management Ltd8.09%1,039,95414,684

People Also Watch

13.40
MPAA
-2.62%
4.190
SILO
-1.41%
10.70
SKYH
+2.10%
13.97
HOFT
-0.29%
318.93
CSW
+1.76%

FAQ

What Is the Mediwound (NASDAQ: MDWD) Share Price Today?

The Mediwound stock price today is 14.120 USD.

What Stock Exchange Does Mediwound (MDWD) Trade On?

Mediwound is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Mediwound?

The stock symbol (also called a 'ticker') for Mediwound is "MDWD."

What Is the Current Mediwound Market Capitalisation?

As of today, Mediwound (NASDAQ: MDWD) market cap is 181.220M USD.

What Is Mediwound's (MDWD) Earnings Per Share (TTM)?

The Mediwound EPS is currently -2.195 (Trailing Twelve Months).

When Is the Next Mediwound Earnings Date?

Mediwound's next earnings report will be released on 13/08/2026.

Is MDWD a Buy or Sell From a Technical Analyst Perspective?

Based on today's Mediwound moving averages and other technical indicators, the daily buy/sell signal for MDWD stock is Strong Sell.

How Many Times Has Mediwound Stock Split?

Mediwound has split 1 times. (See the MDWD stock split history page for full effective split date and price information.)

How Many Employees Does Mediwound Have?

Mediwound has 121 employees, based on their latest Companies House report.

What is the current trading status of Mediwound (NASDAQ: MDWD)?

As of 01/08/2026, Mediwound (MDWD) is trading at a share price of 14.120 USD, with a previous close of 14.100 USD. The stock has fluctuated within a day range of 13.910 USD to 14.565 USD, while its 52-week range spans from 13.540 USD to 20.300 USD.

What Is Mediwound (MDWD) Price Target According to Analysts?

The average 12-month price target for Mediwound is 30.167 USD, with a high estimate of 36 USD and a low estimate of 22 USD. 6 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +113.64% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.